Get started
UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)

UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0YC0 trade ideas

UBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalystNASDAQ:UBX and rises over 100 % in premarket, Has a new product for macular degeneration, a widespread medical problem affecting vision in the elderly which is increasing in incidence. The earning beat was significant. Chart demonstrates the uptrend and midrange RSI but does not show today's premarket. 40 % rise in the week leading up to earnings and now parabolic. doubling overnight. * Get in the party now, don't be late. If you are late stay home" ( not a recommendation to buy only education)
NASDAQ:UBXLong
by AwesomeAvani
2
Invest like Jeff Bezos & Peter Thiel, buy longevity stocks.Have you ever wondered what you like to buy with your money if you were super-rich? Maybe buy something that would make you live longer? Well the problem is that doesn't really exist yet, which is why people are/should invest in this company 😃 www.cnbc.com There are different longevity-related stocks, but this one seems to be the one currently that looks most promising. The reason is that the "Long Now" Jeff Bezos and "Venture capitalist" Peter Thiel is behind it. I personally see this as a long-term play, especially now that BioTech is starting to get momentum.
NASDAQ:UBXLong
by Majnoonu
1
$UBX Long-Term Target $18.90Unity Biotechnology is a pharmaceutical company focused on creating a drug that will extend the years people can live unburdened by disease. This drug has shown a great deal of promise and is currently in phase two clinical trials. As the trials progress, we can expect the price to rise dramatically, and given the current uptrend, My forecast is $18.90 by May 2022. However, that could just be the beginning. This stock is not very popular yet, as it is very few hedge funds. This means that if phase two goes well, Unity Biotech could grow to ridiculous prices. We could be looking at the next AMGN or VRTX. This company is an extremely good investment. Like and follow for more biotech ideas :) Happy Trading!
NASDAQ:UBXLong
by CobraTrader13
UBX Likely to See $9 Again SoonUnity Biotechnology shares almost hit $10 a couple of weeks ago, and since peaking they have shed almost a third of their value, finding support in the process. I have been a long-term investor in UBX for around four months now, and I bought additional shares on Friday because of this stellar entry point. UBX has been very reliable in past months with this support line, and I think shares could easily push up to $12 this month. For the short term I am targeting around $9.90. Good Luck!
NASDAQ:UBXLong
by Investor4321
1
UBX: Long, 450% profitThe price of UBX dropped over 60% after the announcement of bad results of the study of UBX0101 (treatment for knees osteoarthritis). Despite these bad results, UNITY Biotechnology has great potential since they do not focus only on one study. For example, they work on UBX1325, a treatment focused on retinal disease. In the last announcement, they state that they have enough money to fund operations well into 2022. Enter price: Market Price target: $15 or even more This is an idea, but not advice.
NASDAQ:UBXLong
by aleksandr_investor
1